{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:20:16Z","timestamp":1794108016178,"version":"4.8.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This retrospective cohort study investigates the effects of probiotic supplementation on the nutritional, cognitive, and motor functions of elderly survivors recovering from ischemic stroke. Given the high prevalence of nutritional deficits and cognitive impairments in this population, exploring adjunct therapies such as probiotics could provide improved outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study included 223 elderly ischemic stroke survivors treated between March 2021 and February 2024, divided into two groups based on treatment modalities: the Conventional Group (\n                      <jats:italic>n\u202f=<\/jats:italic>\n                      \u202f117) receiving standard enteral nutrition, and the Supplement Group (\n                      <jats:italic>n\u202f=<\/jats:italic>\n                      \u202f106) receiving similar nutrition plus probiotics. Data collected included NIH Stroke Scale (NIHSS), nutritional indicators, cognitive assessments (MMSE, HDS, CDR, SES), and motor evaluations (STREAM, mRS, MBI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline comparisons showed no significant differences between groups. Post-treatment outcomes demonstrated significant improvements in the Supplement Group across several measures. Neurotrophic and nutritional parameters, including BDNF, hemoglobin, albumin, and prealbumin levels, significantly increased (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f\u2264\u202f0.011). Cognitive function also improved, with higher MMSE and HDS scores and reduced CDR scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.003). Motor function, evaluated by STREAM, showed enhanced upper and lower limb mobility and basic activities (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f\u2264\u202f0.014). Further, participants in the Supplement Group experienced better functional recovery with decreased mRS scores and increased MBI scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.004). The incidence of gastrointestinal adverse events was significantly reduced in the Supplement Group (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), and correlation analysis underscored positive associations between probiotics and improved outcomes (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f\u2264\u202f0.003).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Probiotic supplementation as part of nutritional therapy significantly enhances nutritional, cognitive, and motor function recovery in elderly ischemic stroke survivors, while also reducing gastrointestinal adverse events. These findings suggest that incorporating probiotics into recovery protocols post-stroke may facilitate better health outcomes and provide a well-tolerated therapeutic adjunct.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1833163","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:38:19Z","timestamp":1782103099000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of probiotic supplements on cognitive outcomes and neuroplasticity in elderly ischemic stroke survivors"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaohong","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of General Affairs, The Second Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"ref1","first-page":"284","article-title":"Ischemic stroke and Dysbiosis of gut microbiota: changes to LPS levels and effects on functional outcomes","volume":"29","author":"Jiang","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s12031-023-02149-4","article-title":"Analysis of fecal microbiota in patients with hypertension complicated with ischemic stroke","volume":"73","author":"Jiang","year":"2023","journal-title":"J Mol Neurosci MN"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1007\/s12035-023-03473-x","article-title":"Microbiota metabolites and immune regulation affect ischemic stroke occurrence, development, and prognosis","volume":"60","author":"Wang","year":"2023","journal-title":"Mol Neurobiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s12975-022-01096-3","article-title":"Gut microbiota in ischemic stroke: role of gut Bacteria-derived metabolites","volume":"14","author":"Zhang","year":"2023","journal-title":"Transl Stroke Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s12975-023-01151-7","article-title":"The involvement of immune cells between ischemic stroke and gut microbiota","volume":"15","author":"Pu","year":"2024","journal-title":"Transl Stroke Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"114026","DOI":"10.1016\/j.biopha.2022.114026","article-title":"The mechanism of intestinal microbiota regulating immunity and inflammation in ischemic stroke and the role of natural botanical active ingredients in regulating intestinal microbiota: a review","volume":"157","author":"Zeng","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"114559","DOI":"10.1016\/j.biopha.2023.114559","article-title":"New insight into gut microbiota and their metabolites in ischemic stroke: a promising therapeutic target","volume":"162","author":"Zhang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"103676","DOI":"10.1016\/j.ebiom.2021.103676","article-title":"Vitamin B12 and gut-brain homeostasis in the pathophysiology of ischemic stroke","volume":"73","author":"Roth","year":"2021","journal-title":"EBioMedicine"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"104403","DOI":"10.1016\/j.phrs.2019.104403","article-title":"Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota","volume":"148","author":"Chen","year":"2019","journal-title":"Pharmacol Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"106714","DOI":"10.1016\/j.phrs.2023.106714","article-title":"Gut microbiota-derived melatonin from Puerariae Lobatae Radix-resistant starch supplementation attenuates ischemic stroke injury via a positive microbial co-occurrence pattern","volume":"190","author":"Lian","year":"2023","journal-title":"Pharmacol Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1038\/s41598-021-90463-5","article-title":"Microbiota dysbiosis and functional outcome in acute ischemic stroke patients","volume":"11","author":"Chang","year":"2021","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1391384","article-title":"Could the gut microbiota serve as a therapeutic target in ischemic stroke?","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid Compl Alternative Med eCAM"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/CIRCRESAHA.119.316448","article-title":"Gut microbiota-derived short-chain fatty acids promote Poststroke recovery in aged mice","volume":"127","author":"Lee","year":"2020","journal-title":"Circ Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/STROKEAHA.121.036800","article-title":"Gut microbiota and their metabolites in stroke: a double-edged sword","volume":"53","author":"Peh","year":"2022","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1136\/svn-2023-002998","article-title":"Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update","volume":"8","author":"Liu","year":"2023","journal-title":"Stroke Vas Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e0249211","DOI":"10.1371\/journal.pone.0249211","article-title":"Validation of a Polish version of the National Institutes of Health stroke scale: do moderate psychometric properties affect its clinical utility?","volume":"16","author":"Wi\u015bniewski","year":"2021","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF01354540","article-title":"A protocol for the videofluorographic swallowing study","volume":"8","author":"Palmer","year":"1993","journal-title":"Dysphagia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/23279095.2022.2046583","article-title":"Cross-cultural adaptation of the Moroccan version of the Mini-mental state examination: a preliminary study","volume":"31","author":"Rami","year":"2022","journal-title":"Appl Neuropsychol Adult"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s40615-018-00560-x","article-title":"Psychometric properties of a healthcare discrimination scale among young-adult Latinos","volume":"6","author":"L\u00f3pez-Cevallos","year":"2019","journal-title":"J Racial Ethn Health Disparities"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jalz.2011.01.005","article-title":"Suitability of the clinical dementia rating-sum of boxes as a single primary endpoint for Alzheimer's disease trials","volume":"7","author":"Coley","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1251.e21","DOI":"10.1016\/j.jvoice.2022.03.015","article-title":"Development and initial psychometric evaluation of the self-efficacy scale for voice modification in trans women","volume":"38","author":"Dacakis","year":"2024","journal-title":"J Voice Off"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ptj\/79.1.8","article-title":"Reliability of scores on the stroke rehabilitation assessment of movement (STREAM) measure","volume":"79","author":"Daley","year":"1999","journal-title":"Phys Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1161\/STROKEAHA.113.002266","article-title":"Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points","volume":"44","author":"McArthur","year":"2013","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1080\/09638288.2020.1814429","article-title":"A comparison of test-retest reliability and random measurement error of the Barthel index and modified Barthel index in patients with chronic stroke","volume":"44","author":"Yang","year":"2022","journal-title":"Disabil Rehabil"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1177\/0271678X231162648","article-title":"Gut microbiota-associated metabolites and risk of ischemic stroke in REGARDS","volume":"43","author":"Ament","year":"2023","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Metabolism"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12866-019-1552-1","article-title":"Change of intestinal microbiota in cerebral ischemic stroke patients","volume":"19","author":"Li","year":"2019","journal-title":"BMC Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12967-022-03669-0","article-title":"Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke","volume":"20","author":"Zhao","year":"2022","journal-title":"J Transl Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40001-022-00691-2","article-title":"Ischemic stroke and intestinal flora: an insight into brain-gut axis","volume":"27","author":"Hu","year":"2022","journal-title":"Eur J Med Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2147\/IJGM.S353276","article-title":"Relationships among gut microbiota, ischemic stroke and its risk factors: based on research evidence","volume":"15","author":"Huang","year":"2022","journal-title":"Int J Gen Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1334581","DOI":"10.3389\/fcimb.2024.1334581","article-title":"Role of the gut microbiota in complications after ischemic stroke","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"845243","DOI":"10.3389\/fimmu.2022.845243","article-title":"The role of the gut microbiota in the development of ischemic stroke","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1141387","DOI":"10.3389\/fimmu.2023.1141387","article-title":"The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke","volume":"14","author":"Wei","year":"2023","journal-title":"Front Immunol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1324018","DOI":"10.3389\/fimmu.2024.1324018","article-title":"Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update","volume":"15","author":"Hediyal","year":"2024","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"871720","DOI":"10.3389\/fncel.2022.871720","article-title":"Novel mechanisms and therapeutic targets for ischemic stroke: a focus on gut microbiota","volume":"16","author":"Bao","year":"2022","journal-title":"Front Cell Neurosci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1833163\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:38:24Z","timestamp":1782103104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1833163\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":34,"alternative-id":["10.3389\/fneur.2026.1833163"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1833163","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1833163"}}